Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thioctacid for diabetic distal symmetric polyneuropathy
NCT01224353Phase 3Unknown
- Sponsor
- NovaMed Pharmaceuticals
- Start
- Nov 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in distal symmetric polyneuropathy (DSP), sponsored by NovaMed Pharmaceuticals. Status: unknown.
02
Drugs
alpha-lipoic acid
03
Conditions
distal symmetric polyneuropathy (DSP)
Beyond the preview
Go deeper on NCT01224353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224353.